Herrera C - Search Results

1

Maraviroc and reverse transcriptase inhibitors combinations as potential preexposure prophylaxis candidates.

Herrera C, Armanasco N, García-Pérez J, Ziprin P, Olejniczak N, Alcamí J, Nuttall J, Shattock RJ. Herrera C, et al. AIDS. 2016 Apr 24;30(7):1015-25. doi: 10.1097/QAD.0000000000001043. AIDS. 2016. PMID: 26854808 Free article.

2

Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.

Cranage M, Sharpe S, Herrera C, Cope A, Dennis M, Berry N, Ham C, Heeney J, Rezk N, Kashuba A, Anton P, McGowan I, Shattock R. Cranage M, et al. Among authors: herrera c. PLoS Med. 2008 Aug 5;5(8):e157; discussion e157. doi: 10.1371/journal.pmed.0050157. PLoS Med. 2008. PMID: 18684007 Free PMC article.

3

Reverse transcriptase inhibitors as potential colorectal microbicides.

Herrera C, Cranage M, McGowan I, Anton P, Shattock RJ. Herrera C, et al. Antimicrob Agents Chemother. 2009 May;53(5):1797-807. doi: 10.1128/AAC.01096-08. Epub 2009 Mar 2. Antimicrob Agents Chemother. 2009. PMID: 19258271 Free PMC article.

4

CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic.

Abraha A, Nankya IL, Gibson R, Demers K, Tebit DM, Johnston E, Katzenstein D, Siddiqui A, Herrera C, Fischetti L, Shattock RJ, Arts EJ. Abraha A, et al. Among authors: herrera c. J Virol. 2009 Jun;83(11):5592-605. doi: 10.1128/JVI.02051-08. Epub 2009 Mar 18. J Virol. 2009. PMID: 19297481 Free PMC article.

5

Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants.

Herrera C, Cranage M, McGowan I, Anton P, Shattock RJ. Herrera C, et al. AIDS. 2011 Oct 23;25(16):1971-9. doi: 10.1097/QAD.0b013e32834b3629. AIDS. 2011. PMID: 21811139

6

Potential use of protease inhibitors as vaginal and colorectal microbicides.

Herrera C, Shattock RJ. Herrera C, et al. Curr HIV Res. 2012 Jan 1;10(1):42-52. doi: 10.2174/157016212799304607. Curr HIV Res. 2012. PMID: 22264045

7

Preclinical evaluation of the HIV-1 fusion inhibitor L'644 as a potential candidate microbicide.

Harman S, Herrera C, Armanasco N, Nuttall J, Shattock RJ. Harman S, et al. Among authors: herrera c. Antimicrob Agents Chemother. 2012 May;56(5):2347-56. doi: 10.1128/AAC.06108-11. Epub 2012 Feb 13. Antimicrob Agents Chemother. 2012. PMID: 22330930 Free PMC article.

8

Saquinavir inhibits early events associated with establishment of HIV-1 infection: potential role for protease inhibitors in prevention.

Stefanidou M, Herrera C, Armanasco N, Shattock RJ. Stefanidou M, et al. Among authors: herrera c. Antimicrob Agents Chemother. 2012 Aug;56(8):4381-90. doi: 10.1128/AAC.00399-12. Epub 2012 Jun 4. Antimicrob Agents Chemother. 2012. PMID: 22664974 Free PMC article.

9

MiniCD4 microbicide prevents HIV infection of human mucosal explants and vaginal transmission of SHIV(162P3) in cynomolgus macaques.

Dereuddre-Bosquet N, Morellato-Castillo L, Brouwers J, Augustijns P, Bouchemal K, Ponchel G, Ramos OH, Herrera C, Stefanidou M, Shattock R, Heyndrickx L, Vanham G, Kessler P, Le Grand R, Martin L. Dereuddre-Bosquet N, et al. Among authors: herrera c. PLoS Pathog. 2012;8(12):e1003071. doi: 10.1371/journal.ppat.1003071. Epub 2012 Dec 6. PLoS Pathog. 2012. PMID: 23236282 Free PMC article.

10

Candidate microbicides and their mechanisms of action.

Herrera C, Shattock RJ. Herrera C, et al. Curr Top Microbiol Immunol. 2014;383:1-25. doi: 10.1007/82_2013_326. Curr Top Microbiol Immunol. 2014. PMID: 23612992 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,027 results

Search Page